Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Baseline Tumor Transcriptome Characteristics Associated with the Response of Relapsed/Refractory Hodgkin Lymphoma Patients to Brentuximab Vedotin in Combination with Nivolumab

Daniel E. Zak, PhD, Carol Anne Anne Ogden, PhD, Alex F. Herrera, MD, Mariana Sacchi, MD, Matt Onsum, PhD

Blood (2018) 132 (Supplement 1): 2837.

https://doi.org/10.1182/blood-2018-99-115481

Published: 2018

Journal Articles

Deferasirox Associated to Liver Failure and Death in a Sickle Cell Anemia Patient Homozygous for the -1774delG Polymorphism in the ABCC2 Gene Encoding Multidrug Resistance Protein 2 (MRP2)

Caroline Cordeiro Barroso Braga, Bruno Deltreggia Benites, MD, Dulcineia M de Albuquerque, Marisa Claudia Alvarez, Fernando F Costa, PhD MD, Simone C O Gilli, MD PhD, Sara T.O. Saad, MD PhD

Blood (2016) 128 (22): 4822.

https://doi.org/10.1182/blood.V128.22.4822.4822

Published: 2016

Journal Articles

Role of Genetic Polymorphisms on Response to R-Chopregimen in Diffuse Large B-Cell Lymphoma Patients: An Interim Analysis of a Multicenter Prospective Pharmacogenetic Study

Blood (2015) 126 (23): 2483.

https://doi.org/10.1182/blood.V126.23.2483.2483

Published: 2015

Journal Articles

Genome-Wide Association Study of Overall and Progression-Free Survival after HLA-Matched Unrelated Donor Blood and Marrow Transplantation (DISCOVeRY-BMT study)

Blood (2015) 126 (23): 397.

https://doi.org/10.1182/blood.V126.23.397.397

Published: 2015

Journal Articles

Impact of Transporter Genes Polymorphisms in Standard Induction of Acute Myeloid Leukemia

Juan Eduardo Megías, PharmD, Pau Montesinos, MD, María José Herrero, PhD, Federico Moscardó, Virginia Bosó, PharmD, David Martínez-Cuadrón, MD, Luis Rojas, MD, Rebeca Rodríguez-Veiga, MD, Blanca Boluda, MD, Jesús Martínez, MD, Jaime Sanz, MD, Francisca López, MD, Isabel Cano, MD, Aima Lancharro, MD, Jose Cervera, MD, David Hervás, José Luis Poveda, PhD, Salvador F Aliño, PhD, Miguel Ángel Sanz, MD PhD

Blood (2015) 126 (23): 4842.

https://doi.org/10.1182/blood.V126.23.4842.4842

Published: 2015

Journal Articles

Integrating Molecular, Epigenetic and Pharmacogenetic Approaches in Managing Imatinib Resistance Among Malaysian Chronic Myeloid Leukemia Patients

Aziz Baba, MDFRCP, Marjanu Hikmah Elias, Anthony Zian Au, Najlaa Maddin, Siti Maziras Makhtar, Gan Siew Hua, PhD, Azlan Husin, MD, Sarina Sulong, PhD, Rosline Hassan, MD, Ravindran Ankathil, PhD

Blood (2014) 124 (21): 3150.

https://doi.org/10.1182/blood.V124.21.3150.3150

Published: 2014

Journal Articles

The Family Members of Mrps Expression and significance in Childhood Acute Lymphoblastic Leukemia

Baoling Qiu, Dong WU, Qi Zhou, Dan Hong, Jian Pan, PhD, Shaoyan Hu, MD PhD

Blood (2014) 124 (21): 5191.

https://doi.org/10.1182/blood.V124.21.5191.5191

Published: 2014

Journal Articles

Genetic Polymorphisms In Candidate Genes Predict Increased Toxicity With Methotrexate Therapy In Children With Acute Lymphoblastic Leukemia In Lebanon

Nathalie K Zgheib, MD, Maya Akra-Ismail, Carol Aridi, MD, Rami Mahfouz, MD, MPH, Raya Saab, MD, Miguel R. Abboud, MD, MHA, Hassan Solh, MD, Samar A. Muwakkit, MD

Blood (2013) 122 (21): 4926.

https://doi.org/10.1182/blood.V122.21.4926.4926

Published: 2013

Journal Articles

Treatment of Aggressive B-Cell Lymphoma in the Elderly: The Influence of SNPs Affecting Pharmacodynamics Is Different Compared to Younger Patient

Thomas Melchardt, MD, Lukas Weiss, MD, Clemens Hufnagl, Daniel Neureiter, MD, Ralf Kemmerling, MD, Patrick Morre, Ann Boekstegers, Georg Hopfinger, MD, Richard Greil, MD, Alexander Egle, MD

Blood (2012) 120 (21): 1613.

https://doi.org/10.1182/blood.V120.21.1613.1613

Published: 2012

Journal Articles

Genetic Susceptibility to Anthracycline-Related Congestive Heart Failure (CHF) in Survivors of Hematopoietic Cell Transplantation (HCT)

Saro H. Armenian, DO, MPH, Yan Ding, PhD, George Mills, III, Can-Lan Sun, PhD, Kalyanasundaram Venkatraman, MD, F. Lennie Wong, PhD, David Senitzer, PhD, Shirong Wang, MD, Stephen J. Forman, MD, Smita Bhatia, MD, MPH

Blood (2012) 120 (21): 589.

https://doi.org/10.1182/blood.V120.21.589.589

Published: 2012

Journal Articles

Single Nucleotide Polymorphisms (SNPs) in Genes for Glutathione-Related Metabolism, Cyclin D1, and DNA Repair As Predictive Biomarkers in Mantle Cell Lymphoma Patients Treated with R-HyperCVAD with Ten Year Clinical Follow-up,

Michael A. Thompson, MD, PhD, Caimiao Wei, PhD, Ann M Moyer, PhD, Julie M Cunningham, PhD, Luhua Wang, MD, Luis Fayad, MD, Lei Feng, Ph.D, Maria Alma Rodriguez, MD, Fernando Cabanillas, MD, Hagop M. Kantarjian, Larry W Kwak, MD, PhD, Jorge E Romaguera, MD

Blood (2011) 118 (21): 3650.

https://doi.org/10.1182/blood.V118.21.3650.3650

Published: 2011

Journal Articles

Transcriptome of Expressed Genes in CD34+ and CD66b+ Chronic Myeloid Leukemia Cells and Its Potential Role in the Transport of Kinase Inhibitors

Caroline Fátima Aquino Moreira-Nnes, MsC, Ana Cristina Simões Beltrão, MD, MSc, Tereza Cristina Brito Azevedo, MD, MSc, Larissa Tatiana Valente Martins Francês, MD, MSc, Rodrigo Guarischi Mattos Amaral Sousa, MSc, Israel Tojal Silva, PhD, Artur Luiz Costa Silva, PhD, Wilson Araújo Silva-Jr, PhD, José Alexandre Rodrigues Lemos, PhD

Blood (2011) 118 (21): 4426.

https://doi.org/10.1182/blood.V118.21.4426.4426

Published: 2011

Journal Articles

Pharmacogenetic Study of Deferasirox, An Iron Chelating Agent

Hyoung Jin Kang, Ji Won Lee, Ji-Yeob Choi, Nam Hee Kim, Mi Kyung Jang, Chang-Woo Yeo, Sang-Seop Lee, Eun Jong Han, Hyery Kim, Kyung Duk Park, Hee Young Shin, Jae-Gook Shin, Hyo Seop Ahn

Blood (2010) 116 (21): 2060.

https://doi.org/10.1182/blood.V116.21.2060.2060

Published: 2010

Journal Articles

Trough Plasma Imatinib Levels and ABCG2 Polymorphisms Are Correlated with Optimal Cytogenetic Responses at 6 Months After Treatment with Standard Dose of Imatinib In Newly Diagnosed CML

Blood (2010) 116 (21): 2272.

https://doi.org/10.1182/blood.V116.21.2272.2272

Published: 2010

Journal Articles

Genetic Polymorphisms In Genes Involved In R-CHOP Metabolism and Event-Free and Overall Survival In Diffuse Large B-Cell Lymphoma

James R Cerhan, MD, PhD, Thomas M Habermann, MD, Matthew J Maurer, MS, James E Wooldridge, MD, Stephen M Ansell, MD, PhD, Grzegorz S. Nowakowski, MD, Ivana N Micallef, MD, Carrie A Thompson, MD, Alice H Wang, BA, William R Macon, MD, Sergei I Syrbu, MD, Susan L Slager, PhD, Thomas E Witzig, MD, Brian Link

Blood (2010) 116 (21): 996.

https://doi.org/10.1182/blood.V116.21.996.996

Published: 2010

Journal Articles

ABCG2 C.421C>A Is Associated with Higher Trough Imatinib Plasma Levels in Patients with Chronic Myeloid Leukemia.

Naoto Takahashi, MD, PhD, FJSIM, Masatomo Miura, PhD, Stuart A Scott, PhD, FACMG, Kenichi Sawada, MD, PhD

Blood (2009) 114 (22): 110.

https://doi.org/10.1182/blood.V114.22.110.110

Published: 2009

Journal Articles

Imatinib and Nilotinib Intracytoplasmic Determination Levels.

Stephane Bouchet, Stephanie Dulucq, Karine Titier, Nicholas Moore, Mathieu Molimard, Francois-Xavier Mahon

Blood (2009) 114 (22): 2750.

https://doi.org/10.1182/blood.V114.22.2750.2750

Published: 2009

Journal Articles

Mechanism Research of Magnetic Nanoparticle Fe 3 O 4 and 5-Bromotetrandrine On Reversal of Multidrug Resistance in K562/A02 Leukemic Cells.

Bao-An Chen, Wei-Wei Wu, Jian Cheng, Feng Gao, Wen-Lin Xu, Chong Gao, Jia-Hua Ding, Xin-Chen Sun, Cui-Rong Xu, Ning-Na Chen, Guo-Hua Xia, Xue-Mei Wang, Wen-Ji Chen, Li-Jie Liu, Xiao-Mao Li

Blood (2009) 114 (22): 4827.

https://doi.org/10.1182/blood.V114.22.4827.4827

Published: 2009

Journal Articles

Genetic Variation in ADME Genes Is Associated with Thalidomide Related Peripheral Neuropathy in Multiple Myeloma Patients.

David C Johnson, Christine Ramos, Alex J. Szubert, Walter M Gregory, J. Anthony Child, Faith E Davies, MD, Brian GM Durie, MD, Brian G. Van Ness, PhD, Gareth J Morgan, MD, PhD

Blood (2008) 112 (11): 1675.

https://doi.org/10.1182/blood.V112.11.1675.1675

Published: 2008

Journal Articles

The Pharmacogenetic Background of the Host Is An Independent Predictor of Outcome and Toxicity in Diffuse Large B Cell Lymphoma Treated with R-CHOP21

Davide Rossi, Silvia Rasi, Silvia Franceschetti, Daniela Capello, Andrea Castelli, Lorenzo De Paoli, Antonio Ramponi, Annalisa Chiappella, Enrico M. Pogliani, Umberto Vitolo, Ivo Kwee, Francesco Bertoni, Annarita Conconi, Gianluca Gaidano

Blood (2008) 112 (11): 480.

https://doi.org/10.1182/blood.V112.11.480.480

Published: 2008

NARROW

Baseline Tumor Transcriptome Characteristics Associated with the Response of Relapsed/Refractory Hodgkin Lymphoma Patients to Brentuximab Vedotin in Combination with Nivolumab

Deferasirox Associated to Liver Failure and Death in a Sickle Cell Anemia Patient Homozygous for the -1774delG Polymorphism in the ABCC2 Gene Encoding Multidrug Resistance Protein 2 (MRP2)

Role of Genetic Polymorphisms on Response to R-Chopregimen in Diffuse Large B-Cell Lymphoma Patients: An Interim Analysis of a Multicenter Prospective Pharmacogenetic Study

Genome-Wide Association Study of Overall and Progression-Free Survival after HLA-Matched Unrelated Donor Blood and Marrow Transplantation (DISCOVeRY-BMT study)

Impact of Transporter Genes Polymorphisms in Standard Induction of Acute Myeloid Leukemia

Integrating Molecular, Epigenetic and Pharmacogenetic Approaches in Managing Imatinib Resistance Among Malaysian Chronic Myeloid Leukemia Patients

The Family Members of Mrps Expression and significance in Childhood Acute Lymphoblastic Leukemia

Genetic Polymorphisms In Candidate Genes Predict Increased Toxicity With Methotrexate Therapy In Children With Acute Lymphoblastic Leukemia In Lebanon

Treatment of Aggressive B-Cell Lymphoma in the Elderly: The Influence of SNPs Affecting Pharmacodynamics Is Different Compared to Younger Patient

Genetic Susceptibility to Anthracycline-Related Congestive Heart Failure (CHF) in Survivors of Hematopoietic Cell Transplantation (HCT)

Single Nucleotide Polymorphisms (SNPs) in Genes for Glutathione-Related Metabolism, Cyclin D1, and DNA Repair As Predictive Biomarkers in Mantle Cell Lymphoma Patients Treated with R-HyperCVAD with Ten Year Clinical Follow-up,

Transcriptome of Expressed Genes in CD34+ and CD66b+ Chronic Myeloid Leukemia Cells and Its Potential Role in the Transport of Kinase Inhibitors

Pharmacogenetic Study of Deferasirox, An Iron Chelating Agent

Trough Plasma Imatinib Levels and ABCG2 Polymorphisms Are Correlated with Optimal Cytogenetic Responses at 6 Months After Treatment with Standard Dose of Imatinib In Newly Diagnosed CML

Genetic Polymorphisms In Genes Involved In R-CHOP Metabolism and Event-Free and Overall Survival In Diffuse Large B-Cell Lymphoma

ABCG2 C.421C>A Is Associated with Higher Trough Imatinib Plasma Levels in Patients with Chronic Myeloid Leukemia.

Imatinib and Nilotinib Intracytoplasmic Determination Levels.

Mechanism Research of Magnetic Nanoparticle Fe 3 O 4 and 5-Bromotetrandrine On Reversal of Multidrug Resistance in K562/A02 Leukemic Cells.

Genetic Variation in ADME Genes Is Associated with Thalidomide Related Peripheral Neuropathy in Multiple Myeloma Patients.

The Pharmacogenetic Background of the Host Is An Independent Predictor of Outcome and Toxicity in Diffuse Large B Cell Lymphoma Treated with R-CHOP21

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only